DEEPNOID INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,630 KRW | +0.26% |
|
+7.46% | -29.19% |
| 2023 | DeepNoid to Raise 17.9 Billion Won via Stock Offering | MT |
| 2023 | DEEPNOID Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| Sales 2022 | 3.18B 2.31M | Sales 2023 | 1.93B 1.41M | Capitalization | 238B 173M |
|---|---|---|---|---|---|
| Net income 2022 | -5.33B -3.88M | Net income 2023 | -6.74B -4.9M | EV / Sales 2022 | 13.4 x |
| Net cash position 2022 | 10.21B 7.42M | Net cash position 2023 | 28.5B 20.72M | EV / Sales 2023 | 109 x |
| P/E ratio 2022 |
-4.95
x | P/E ratio 2023 |
-15.4
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 19.29% |
More Fundamentals
* Assessed data
| 1 day | +0.26% | ||
| 1 week | +7.46% | ||
| Current month | -14.94% | ||
| 1 month | -12.35% | ||
| 3 months | -27.68% | ||
| 6 months | -23.70% | ||
| Current year | -29.19% |
1 week
7 180.00
7 940.00
1 month
7 000.009 385.00
Current year
7 000.0012 375.00
1 year
3 905.0016 475.00
3 years
2 620.0019 500.00
5 years
2 620.0019 500.00
10 years
2 620.0019 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Woo-Sik Choi
CEO | Chief Executive Officer | 55 | 07-12-31 |
Jong-Chae Jung
DFI | Director of Finance/CFO | 51 | 17-12-31 |
Tae-Kyu Kim
CTO | Chief Tech/Sci/R&D Officer | 50 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Seok-Cheol Jeon
BRD | Director/Board Member | 41 | - |
Woo-Sik Choi
CEO | Chief Executive Officer | 55 | 07-12-31 |
Jong-Chae Jung
DFI | Director of Finance/CFO | 51 | 17-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 7,440 | -2.49% | 40,895 |
| 24-04-24 | 7,630 | +0.26% | 60,339 |
| 24-04-23 | 7,610 | 0.00% | 99,637 |
| 24-04-22 | 7,610 | -0.52% | 107,087 |
| 24-04-19 | 7,650 | -2.55% | 112,302 |
End-of-day quote Korea S.E., April 23, 2024
More quotes
Deep Noid Inc is a Korea-based company principally engaged in the medical artificial intelligence (AI) solutions. The Company a virtuous cycle of medical AI ecosystem based on a continuous and integrated all-in-one medical AI platform for accurate and efficient research and an AI clinical decision support system for actual clinical application. The Company's main products include DEEP:AI, DEEP:PHI, DEEP:STORE, and DEEP:PACS.
Sector
IT Services & Consulting
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -29.19% | 124M | |
| +17.97% | 3.99B | |
| -32.86% | 1.66B | |
| -54.02% | 820M | |
| -28.62% | 566M | |
| -15.67% | 325M | |
| -31.31% | 288M | |
| +16.32% | 239M | |
| -10.71% | 209M | |
| +87.84% | 132M |
- Stock Market
- Equities
- A315640 Stock
